红细胞输血阈值与接受体外膜氧合治疗的急性呼吸衰竭内科患者结局的关联:单中心回顾性队列研究
这项单中心回顾性队列研究纳入229例接受静脉-静脉体外膜氧合(ECMO)的患者,比较无阈值(91例)、血红蛋白<8 g/dL(48例)和血红蛋白<7 g/dL(90例)三个输血阈值队列。实施阈值后每日ECMO支持的红细胞输注单位数下降(无阈值组0.6±1.0,<8 g/dL组0.3±0.8,<7 g/dL组0.3±1.1;P<.001),但分段回归显示阈值实施与每日红细胞单位数趋势变化无关。与<8 g/dL队列相比,无阈值队列死亡风险升高(aHR 2.08;95%CI 1.12-3.88),<7 g/dL队列死亡风险也升高(aHR 1.93;95%CI 1.02-3.62);无阈值与<7 g/dL队列间无差异(aHR 1.08;95%CI 0.69-1.69)。作者认为<8 g/dL阈值与较低死亡风险相关,但受方法学限制,需进一步研究。
要点
- 与血红蛋白<8 g/dL阈值相比,无阈值输血与死亡风险升高相关(aHR 2.08;95%CI 1.12-3.88)。
- 与血红蛋白<8 g/dL阈值相比,血红蛋白<7 g/dL阈值与死亡风险升高相关(aHR 1.93;95%CI 1.02-3.62)。
- 无阈值与血红蛋白<7 g/dL阈值间死亡风险无差异(aHR 1.08;95%CI 0.69-1.69)。
- 实施阈值后每日ECMO支持的红细胞输注单位数下降(无阈值组0.6±1.0,<8 g/dL组0.3±0.8,<7 g/dL组0.3±1.1;P<.001)。
- 分段回归显示输血阈值的实施与每日红细胞单位数趋势变化无关联。
适用人群与场景
- 接受静脉-静脉体外膜氧合(ECMO)的急性呼吸衰竭内科患者,单中心回顾性队列。
研究设计与关键结果
- 单中心回顾性队列研究,纳入229例接受静脉-静脉ECMO的患者:无阈值队列91例,血红蛋白<8 g/dL队列48例,血红蛋白<7 g/dL队列90例。
- 实施不同阈值后每日ECMO支持的红细胞输注单位数下降:无阈值组0.6±1.0,<8 g/dL组0.3±0.8,<7 g/dL组0.3±1.1;P<.001。
- 分段回归显示阈值实施与每日ECMO支持的红细胞单位数趋势变化无关联。
- 与血红蛋白<8 g/dL队列相比,无阈值队列死亡风险升高(aHR 2.08;95%CI 1.12-3.88)。
- 与血红蛋白<8 g/dL队列相比,血红蛋白<7 g/dL队列死亡风险升高(aHR 1.93;95%CI 1.02-3.62)。
- 无阈值队列与血红蛋白<7 g/dL队列间死亡风险无差异(aHR 1.08;95%CI 0.69-1.69)。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究。
- 局限:原文报告研究结果受研究方法学限制;需要进一步研究以探讨静脉-静脉ECMO患者的最佳红细胞输血实践。
对床旁实践的改变
- 作者认为,血红蛋白<8 g/dL的输血阈值与较低的死亡风险相关,但这些发现受研究方法的限制。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The hemoglobin value to trigger RBC transfusion for patients receiving venovenous extracorporeal membrane oxygenation (ECMO) is controversial. Previous guidelines recommended transfusing to a normal hemoglobin level, but recent studies suggest that more RBC transfusions are associated with increased adverse outcomes.
RESEARCH QUESTION: Is implementation of different institutional RBC transfusion thresholds for patients receiving venovenous ECMO associated with changes in RBC use and patient outcomes?
STUDY DESIGN AND METHODS: This single-center retrospective study of patients receiving venovenous ECMO used segmented regression to test associations between implementation of institutional transfusion thresholds and trends in RBC use. Associations with secondary outcomes, including in-hospital survival, also were assessed.
RESULTS: The study included 229 patients: 91 in the no threshold cohort, 48 in the hemoglobin < 8 g/dL cohort, and 90 in the hemoglobin < 7 g/dL cohort. Despite a decrease in number of RBC units transfused per day of ECMO support after implementation of different thresholds (mean ± SD: 0.6 ± 1.0 in the no threshold cohort, 0.3 ± 0.8 in the hemoglobin < 8 g/dL cohort, and 0.3 ± 1.1 in the hemoglobin < 7 g/dL cohort; P < .001), segmented regression showed no association between implementation of transfusion thresholds and changes in trends in number of RBC units per day of ECMO. We observed an increased hazard of death in the no threshold cohort compared with the hemoglobin < 8 g/dL cohort (adjusted hazard ratio [aHR], 2.08; 95% CI, 1.12-3.88) and in the hemoglobin < 7 g/dL cohort compared with the hemoglobin < 8 g/dL cohort (aHR, 1.93; 95% CI, 1.02-3.62). No difference was found in the hazard of death between the no threshold and hemoglobin < 7 g/dL cohorts (aHR, 1.08; 95% CI, 0.69-1.69).
INTERPRETATION: We observed a decrease in number of RBC units per day of ECMO over time, but changes were not associated temporally with implementation of transfusion thresholds. A transfusion threshold of hemoglobin < 8 g/dL was associated with a lower hazard of death, but these findings are limited by study methodology. Further research is needed to investigate optimal RBC transfusion practices for patients supported with venovenous ECMO.
参考来源
- Pratt EH, Pulsipher AM, Moulton NG, et al. Association of RBC Transfusion Thresholds and Outcomes in Medical Patients With Acute Respiratory Failure Supported With Extracorporeal Membrane Oxygenation: A Single-Center Retrospective Cohort Study. Chest. 2024. PMID: 38986867. doi:10.1016/j.chest.2024.05.043
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。